Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
JNGHFDrugs in Pipeline
179
Phase 3 Programs
96
Upcoming Catalysts
29
Next Catalyst
Mar 30, 2026
2dMarket Overview
Stock performance and key metrics
29 upcoming, 4 past
Insulin glargine Phase 2 Results Expected
Primary completion for Insulin glargine trial (NCT06688123) in Type 2 Diabetes
SourceSHR-3167 Phase 2 Results Expected
Primary completion for SHR-3167 trial (NCT06688123) in Type 2 Diabetes
SourceApatinib Mesylate Phase 3 Results Expected
Primary completion for Apatinib Mesylate trial (NCT04342910) in Gastric Cancer
Sourcecamrelizumab Phase 3 Results Expected
Primary completion for camrelizumab trial (NCT04342910) in Gastric Cancer
SourceJSKN003 Phase 3 Results Expected
Primary completion for JSKN003 trial (NCT06079983) in Breast Cancer
SourceCapecitabine tablets Phase 3 Results Expected
Primary completion for Capecitabine tablets trial (NCT06079983) in Breast Cancer
Source23 more catalysts beyond 14 days
Start a 48h free trial to see all upcoming catalysts
HRS-4357 injection
PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer
Carboplatin
Lung Neoplasms
Irinotecan Hydrochloride Liposome Injection (II); Oxaliplatin; 5Fluorouracil; Calcium folinate
First-line Treatment of Metastatic Pancreatic Cancer
Recombinant two-component COVID-19 vaccine (CHO cell)
COVID-19
Almonertinib
Non-small Cell Lung Cancer
Capecitabine tablets
Breast Cancer
Compound Edaravone Injection
Acute Ischemic Stroke
camrelizumab； famitinib malate
Cervical Cancer
Noiiglutide Injection
Type 2 Diabetes
VC005 tablets
Moderate to Severe Atopic Dermatitis
Propofol
Sedation
Pyrotinib in combination with Capecitabine.
HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane
Fluzoparib capsules
Ovarian Cancer
pyrotinib
Non Small Cell Lung
SHR0302
Rheumatoid Arthritis
Paclitaxel Injection
Ovarian Cancer
Remimazolam Tosilate
Sedation
SHR8028 eye drops
Dry Eye Disease
SHR-A1811 for Injection
Early-stage or Locally Advanced HER2-positive Breast Cancer
SHR-A1811
Advanced Non-small Cell Lung Cancer
STSP-0601 for Injection
Hemophilia
SHR-1209
Primary Hypercholesterolemia
INS068 injection
Type 2 Diabetes
Camrelizumab Plus Chemotherapy
Triple Negative Breast Cancer
SHR-A1811 Injection
Advanced Gastric Cancer
Suvemcitug injection, trifluridine/tipiracil tablets
Refractory Metastatic Colorectal Cancer
Fuzuloparib , Abiraterone acetate and Prednisone
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Docetaxel
Non-squamous NSCLC
SHR-A1811 Injection ； Pertuzumab Injection
HER2-PositiveRecurrent or Metastatic Breast Cancer
68Ga-DOTATOC
Advanced Gastroenteropancreatic Neuroendocrine Tumor
Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan
HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Trilaciclib, carboplatin, etoposide，or Topotecan
Extensive-stage Small-cell Lung Cancer
VC004 Capsules
Locally Advanced Solid Tumor
SIM0270
Locally Advanced or Metastatic Breast Cancer
Apatinib Mesylate
Gastric Cancer
paclitaxel
Advanced Esophageal Cancer
SIM0417
COVID-19
Rezvilutamide Tablets
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
SHR6390
Advanced Breast Cancer
Famitinib
Colorectal Cancer Metastatic
HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate
First-line Treatment of Advanced Pancreatic Cancer
HR17031 injection
Adult Patients With Type 2 Diabetes
HRS-8427
Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP)
SHR0410 Injection
Pain
SHR3680
Patients With High-risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
SHR8554 Injection
Pain
Lansoprazole
Reflux Esophagitis
BD0801
Ovarian Cancer
DZD8586
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Sulijia
Advanced Non-small Cell Lung Cancer
Hetrombopag Olamine
Idiopathic Thrombocytopenic Purpura
SHR4640 dose1
Gout
Hetrombopag Olamine+Standard Therapy
Severe Aplastic Anemia
Herombopag tablets
Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery
Camrelizumab、Pemetrexed/ Paclitaxel、Carboplatin/ Cisplatin
Non-Small Cell Lung Cancer With HER2- Mutations
SHR8058 eye drops
Treatment of Dry Eye Disease With Meibomian Gland Dysfunction
SHR4640
Gout
Drug: Pegylated rhG-CSF: 100µg/kg
Breast Cancer
Hetrombopag
Chemotherapy-Induced Thrombocytopenia
Capecitabine/Eribulin/Gemcitabine/Paclitaxel/Nab-paclitaxel
Breast Cancer
ASK120067
Locally Advanced or Metastatic NSCLC
KN046
Advanced Pancreatic Ductal Adenocarcinoma
VC005 low dose group
Moderate to Severe Atopic Dermatitis
FRSW117
Severe Hemophilia A
Tanreqing capsule
Novel Coronavirus Pneumonia
Irinotecan
Esophageal Carcinoma
Shenbai Granules
Gastroenterology
Vicagrel
Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
XLJDOD compound granule
Colon Cancer
SHR-1210
Gastric Cancer
Sorafenib
Locally Advanced or Metastatic and Unresectable HCC
SHR-1316、Paclitaxel (Albumin Bound)、Carboplatin
Non-Small-Cell Lung Cancer
Lutetium (177Lu) Oxodotreotide Injection；long-acting Octreotide
Advanced Gastroenteropancreatic Neuroendocrine Tumor
Rivoceranib (Apatinib)
Hepatocellular Carcinoma (HCC)
Camrelizumab
Solid Tumor
BP102, paclitaxel, carboplatin
Non-small Cell Lung Cancer(NSCLC)
Paracetamol injection
Post-operative Analgesia
ENDOSTAR，cisplatin
Malignant Pleural Effusion
Zanamivir
Influenza A Virus Infection
SHR7280 tablets
Female Subjects Undergoing COH in ART to Prevent Early Ovulation
Remimazolam Tosilate for injection
Operative Sedation of Pediatric
SHR7280；Ganirelix Acetate Injection simulant
Infertile Female Subjects Undergoing Controlled Ovarian Hyperstimulation to Suppress Premature LH Surge and Prevent Early Ovulation
TACE+Camrelizumab+Apatinib mesylate
Hepatocellular Carcinoma
SHR2554; Chidamide analog tablets
Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy
Apatinib
Carcinoma, Hepatocellular
X0002 Spray
KNEE OSTEOARTHRITIS
Nalbuphine Hydrochloride Injection
Postoperative Analgesia
Morphine
Pain
sunvozertinib
Non-Small Cell Lung Cancer
JSKN003
Advanced Solid Tumor
Irinotecan liposome、5-Fluorouracil、Leucovorin
Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy
X842
Reflux Esophagitis
Propofol Medium and Long Chain Fat Emulsion Injection
Sedation in the ICU
Daridorexant
Insomnia Disorder
Capecitabine
Gastric Cancer
Insulin Glargine
Type 2 Diabetes Mellitus
Propofol Injection.
Local Anesthesia Assisted Sedation
SHR0302 Tablets
Non-segmental Vitiligo
HRG2010(I)
Parkinson's Disease
APL-1202 treatment
Non-muscle Invasive Bladder Cancer
RSS0343 Tabella
Adolescent Asthma
Meplazumab for Injection
Malaria
SHR-1020
Recurrent or Metastatic Cervical Cancer
KN026 combination
HER2-positive Solid Tumors
Meropenem
Hospital-acquired Bacterial Pneumonia (HABP)
mFOLFIRINOX
Advanced Pancreatic Cancer
benzbromarone
Hyperuricemia
NH102
Major Depressive Disorder (MDD)
JSKN016
Inoperable Locally Advanced HER2-Negative Breast Cancer
TSL-1502 capsules(low dose)
Breast Cancer Metastatic
Sunitinib
Renal Cell Cancer
DZD6008
Non-Small Cell Lung Cancer
SHR2554/CHOP
Peripheral T-cell Lymphoma
SP2086(50 mg q.d.)/Metformin
Type 2 Diabetes
KN019, 5mg/kg
Rheumatoid Arthritis
RY_SW01 cell injection
Lupus Nephritis
HR18042
Moderate to Severe Acute Pain
KN046 (Recombinant Humanized PD-L1/CTLA-4 Bispecific Single Domain Antibody Fc Fusion Protein Injection)
Advanced Non-small Cell Lung Cancer
KN026 10 mg/kg QW
Gastric/Gastroesophageal Junction Cancer
HRS-4508 tablet
Solid Tumor
Nab-paclitaxel
Triple-negative Breast Cancer
high dose KYG0395
Primary Dysmenorrhea
Enzalutamide OR abiraterone acetate With Prednisone Acetate Tablets
Metastatic Castration Resistant Prostate Cancer
Tofacitinib Citrate Tablets
Active Ankylosing Spondylitis
VC005 groups
Atopic Dermatitis
Palonosetron
Cancer
Basic treatment
Systemic Sclerosis
SHR-1701
Pancreatic Cancer
SHR117887
Type 2 Diabetes
SHR-1703
Asthma With Eosinophilic Phenotype
HR021618
Pain After Abdominal Surgery
HS-10375
Advanced or Metastatic NSCLC
SHR2554; SHR-A2102
Locally Advanced or Metastatic Non-small Cell Lung Cancer
Adebrelimab
Advanced KRAS G12D Mutant Solid Tumors
COVID-19 Vaccine (Vero Cell), Inactivated
COVID-19
FOLFOX4
Advanced Primary Liver Cancer
STSA-1301 subcutaneous injection
Primary Immune Thrombocytopenia (ITP)
Camrelizumab、Rivoceranib
Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation
SSD8432 dose 1/Ritonavir
COVID-19 Patients
HS-20004
Diabetes Mellitus, Type 2
HS-10365 capsules
Nonsmall Cell Lung Cancer
SS109
Male
SHR0302Base gel
Vitiligo
HRS-6209 in Combination with Fulvestrant
Advanced Unresectable or Metastatic Breast Cancer
Pegylated rhG-CSF 100μg/kg
Breast Cancer
SHR-A1904
Advanced Solid Tumors
HRS-9190
Neuromuscular Blockade
FH-006
Malignant Solid Tumor
HS-20094
Type 2 Diabetes
Abiraterone Acetate Tablets (I)
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Mesenchymal Stem Cells (MSCs)
Chronic Radiation Proctitis
HRS-1167 tablets
Prostate Cancer
HRS-4642
Advanced Solid Tumors
HRS4800 tablets
Pain
SHR7280
Endometriosis
HRS-6768
Advanced Solid Tumors
50 mg SP2086
Type 2 Diabetes
SHR- A1811
Gynaecological Malignancies
Endostar
Malignant Pleural Effusion
HRS-6209 Capsules
Breast Cancer
FH-006 ; SHR-1316 ; BP102 ; Cisplatin ; Carboplatin
Lung Cancer
Edaravone Injection
Acute Ischemic Stroke
SHR-1314
Moderate-to-severe Chronic Plaque Psoriasis
HRS-5041 tablets
Prostate Cancer
HR020602 injection
Used to Induce and Implement General Anesthesia in Combination With Sedative Anesthetics (Such as Propofol)
ACC017+FTC/TAF
Infection, Human Immunodeficiency Virus
Fluzoparib+Apatinib
Relapsed Ovarian Cancer
Venetoclax
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Insulin Degludec
Type 2 Diabetes
HRS-6213
Patients With Solid Tumors
ASKB589 Injection
Malignant Solid Tumor
SHR 1210+apatinib
Hepatocellular Carcinoma
Vicagrel 5mg
Coronary Artery Disease
HR19042 Capsules
Autoimmune Hepatitis
Bendamustine hydrochloride injection
Chronic Lymphocytic Leukemia
Human TH-SC01 cell injection
Perianal Fistula
SHR-A1811 combined with Pyrotinib.
HER2-expressing Advanced Solid Tumors
SHR-3167
Type 2 Diabetes
Fluzoparib
Small Cell Lung Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
HRS-4357 injection | Phase 3 | PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer | - | - |
Carboplatin | Phase 3 | Lung Neoplasms | - | - |
Irinotecan Hydrochloride Liposome Injection (II); Oxaliplatin; 5Fluorouracil; Calcium folinate | Phase 3 | First-line Treatment of Metastatic Pancreatic Cancer | - | - |
Recombinant two-component COVID-19 vaccine (CHO cell) | Phase 3 | COVID-19 | - | - |
Almonertinib | Phase 3 | Non-small Cell Lung Cancer | - | - |
Capecitabine tablets | Phase 3 | Breast Cancer | - | - |
Compound Edaravone Injection | Phase 3 | Acute Ischemic Stroke | - | - |
camrelizumab； famitinib malate | Phase 3 | Cervical Cancer | - | - |
Noiiglutide Injection | Phase 3 | Type 2 Diabetes | - | - |
VC005 tablets | Phase 3 | Moderate to Severe Atopic Dermatitis | - | - |
Propofol | Phase 3 | Sedation | - | - |
Pyrotinib in combination with Capecitabine. | Phase 3 | HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane | - | - |
Fluzoparib capsules | Phase 3 | Ovarian Cancer | - | - |
pyrotinib | Phase 3 | Non Small Cell Lung | - | - |
SHR0302 | Phase 3 | Rheumatoid Arthritis | - | - |
Paclitaxel Injection | Phase 3 | Ovarian Cancer | - | - |
Remimazolam Tosilate | Phase 3 | Sedation | - | - |
SHR8028 eye drops | Phase 3 | Dry Eye Disease | - | - |
SHR-A1811 for Injection | Phase 3 | Early-stage or Locally Advanced HER2-positive Breast Cancer | - | - |
SHR-A1811 | Phase 3 | Advanced Non-small Cell Lung Cancer | - | - |
STSP-0601 for Injection | Phase 3 | Hemophilia | - | - |
SHR-1209 | Phase 3 | Primary Hypercholesterolemia | - | - |
INS068 injection | Phase 3 | Type 2 Diabetes | - | - |
Camrelizumab Plus Chemotherapy | Phase 3 | Triple Negative Breast Cancer | - | - |
SHR-A1811 Injection | Phase 3 | Advanced Gastric Cancer | - | - |
Suvemcitug injection, trifluridine/tipiracil tablets | Phase 3 | Refractory Metastatic Colorectal Cancer | - | - |
Fuzuloparib , Abiraterone acetate and Prednisone | Phase 3 | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | - | - |
Docetaxel | Phase 3 | Non-squamous NSCLC | - | - |
SHR-A1811 Injection ； Pertuzumab Injection | Phase 3 | HER2-PositiveRecurrent or Metastatic Breast Cancer | - | - |
68Ga-DOTATOC | Phase 3 | Advanced Gastroenteropancreatic Neuroendocrine Tumor | - | - |
Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan | Phase 3 | HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | - | - |
Trilaciclib, carboplatin, etoposide，or Topotecan | Phase 3 | Extensive-stage Small-cell Lung Cancer | - | - |
VC004 Capsules | Phase 3 | Locally Advanced Solid Tumor | - | - |
SIM0270 | Phase 3 | Locally Advanced or Metastatic Breast Cancer | - | - |
Apatinib Mesylate | Phase 3 | Gastric Cancer | - | - |
paclitaxel | Phase 3 | Advanced Esophageal Cancer | - | - |
SIM0417 | Phase 3 | COVID-19 | - | - |
Rezvilutamide Tablets | Phase 3 | Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | - | - |
SHR6390 | Phase 3 | Advanced Breast Cancer | - | - |
Famitinib | Phase 3 | Colorectal Cancer Metastatic | - | - |
HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate | Phase 3 | First-line Treatment of Advanced Pancreatic Cancer | - | - |
HR17031 injection | Phase 3 | Adult Patients With Type 2 Diabetes | - | - |
HRS-8427 | Phase 3 | Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP) | - | - |
SHR0410 Injection | Phase 3 | Pain | - | - |
SHR3680 | Phase 3 | Patients With High-risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy | - | - |
SHR8554 Injection | Phase 3 | Pain | - | - |
Lansoprazole | Phase 3 | Reflux Esophagitis | - | - |
BD0801 | Phase 3 | Ovarian Cancer | - | - |
DZD8586 | Phase 3 | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | - | - |
Sulijia | Phase 3 | Advanced Non-small Cell Lung Cancer | - | - |
Hetrombopag Olamine | Phase 3 | Idiopathic Thrombocytopenic Purpura | - | - |
SHR4640 dose1 | Phase 3 | Gout | - | - |
Hetrombopag Olamine+Standard Therapy | Phase 3 | Severe Aplastic Anemia | - | - |
Herombopag tablets | Phase 3 | Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery | - | - |
Camrelizumab、Pemetrexed/ Paclitaxel、Carboplatin/ Cisplatin | Phase 3 | Non-Small Cell Lung Cancer With HER2- Mutations | - | - |
SHR8058 eye drops | Phase 3 | Treatment of Dry Eye Disease With Meibomian Gland Dysfunction | - | - |
SHR4640 | Phase 3 | Gout | - | - |
Drug: Pegylated rhG-CSF: 100µg/kg | Phase 3 | Breast Cancer | - | - |
Hetrombopag | Phase 3 | Chemotherapy-Induced Thrombocytopenia | - | - |
Capecitabine/Eribulin/Gemcitabine/Paclitaxel/Nab-paclitaxel | Phase 3 | Breast Cancer | - | - |
ASK120067 | Phase 3 | Locally Advanced or Metastatic NSCLC | - | - |
KN046 | Phase 3 | Advanced Pancreatic Ductal Adenocarcinoma | - | - |
VC005 low dose group | Phase 3 | Moderate to Severe Atopic Dermatitis | - | - |
FRSW117 | Phase 3 | Severe Hemophilia A | - | - |
Tanreqing capsule | Phase 3 | Novel Coronavirus Pneumonia | - | - |
Irinotecan | Phase 3 | Esophageal Carcinoma | - | - |
Shenbai Granules | Phase 3 | Gastroenterology | - | - |
Vicagrel | Phase 3 | Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) | - | - |
XLJDOD compound granule | Phase 3 | Colon Cancer | - | - |
SHR-1210 | Phase 3 | Gastric Cancer | - | - |
Sorafenib | Phase 3 | Locally Advanced or Metastatic and Unresectable HCC | - | - |
SHR-1316、Paclitaxel (Albumin Bound)、Carboplatin | Phase 3 | Non-Small-Cell Lung Cancer | - | - |
Lutetium (177Lu) Oxodotreotide Injection；long-acting Octreotide | Phase 3 | Advanced Gastroenteropancreatic Neuroendocrine Tumor | - | - |
Rivoceranib (Apatinib) | Phase 3 | Hepatocellular Carcinoma (HCC) | - | - |
Camrelizumab | Phase 3 | Solid Tumor | - | - |
BP102, paclitaxel, carboplatin | Phase 3 | Non-small Cell Lung Cancer(NSCLC) | - | - |
Paracetamol injection | Phase 3 | Post-operative Analgesia | - | - |
ENDOSTAR，cisplatin | Phase 3 | Malignant Pleural Effusion | - | - |
Zanamivir | Phase 3 | Influenza A Virus Infection | - | - |
SHR7280 tablets | Phase 3 | Female Subjects Undergoing COH in ART to Prevent Early Ovulation | - | - |
Remimazolam Tosilate for injection | Phase 3 | Operative Sedation of Pediatric | - | - |
SHR7280；Ganirelix Acetate Injection simulant | Phase 3 | Infertile Female Subjects Undergoing Controlled Ovarian Hyperstimulation to Suppress Premature LH Surge and Prevent Early Ovulation | - | - |
TACE+Camrelizumab+Apatinib mesylate | Phase 3 | Hepatocellular Carcinoma | - | - |
SHR2554; Chidamide analog tablets | Phase 3 | Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy | - | - |
Apatinib | Phase 3 | Carcinoma, Hepatocellular | - | - |
X0002 Spray | Phase 3 | KNEE OSTEOARTHRITIS | - | - |
Nalbuphine Hydrochloride Injection | Phase 3 | Postoperative Analgesia | - | - |
Morphine | Phase 3 | Pain | - | - |
sunvozertinib | Phase 3 | Non-Small Cell Lung Cancer | - | - |
JSKN003 | Phase 3 | Advanced Solid Tumor | - | - |
Irinotecan liposome、5-Fluorouracil、Leucovorin | Phase 3 | Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy | - | - |
X842 | Phase 3 | Reflux Esophagitis | - | - |
Propofol Medium and Long Chain Fat Emulsion Injection | Phase 3 | Sedation in the ICU | - | - |
Daridorexant | Phase 3 | Insomnia Disorder | - | - |
Capecitabine | Phase 3 | Gastric Cancer | - | - |
Insulin Glargine | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Propofol Injection. | Phase 2 | Local Anesthesia Assisted Sedation | - | - |
SHR0302 Tablets | Phase 2 | Non-segmental Vitiligo | - | - |
HRG2010(I) | Phase 2 | Parkinson's Disease | - | - |
APL-1202 treatment | Phase 2 | Non-muscle Invasive Bladder Cancer | - | - |
RSS0343 Tabella | Phase 2 | Adolescent Asthma | - | - |
Meplazumab for Injection | Phase 2 | Malaria | - | - |
SHR-1020 | Phase 2 | Recurrent or Metastatic Cervical Cancer | - | - |
KN026 combination | Phase 2 | HER2-positive Solid Tumors | - | - |
Meropenem | Phase 2 | Hospital-acquired Bacterial Pneumonia (HABP) | - | - |
mFOLFIRINOX | Phase 2 | Advanced Pancreatic Cancer | - | - |
benzbromarone | Phase 2 | Hyperuricemia | - | - |
NH102 | Phase 2 | Major Depressive Disorder (MDD) | - | - |
JSKN016 | Phase 2 | Inoperable Locally Advanced HER2-Negative Breast Cancer | - | - |
TSL-1502 capsules(low dose) | Phase 2 | Breast Cancer Metastatic | - | - |
Sunitinib | Phase 2 | Renal Cell Cancer | - | - |
DZD6008 | Phase 2 | Non-Small Cell Lung Cancer | - | - |
SHR2554/CHOP | Phase 2 | Peripheral T-cell Lymphoma | - | - |
SP2086(50 mg q.d.)/Metformin | Phase 2 | Type 2 Diabetes | - | - |
KN019, 5mg/kg | Phase 2 | Rheumatoid Arthritis | - | - |
RY_SW01 cell injection | Phase 2 | Lupus Nephritis | - | - |
HR18042 | Phase 2 | Moderate to Severe Acute Pain | - | - |
KN046 (Recombinant Humanized PD-L1/CTLA-4 Bispecific Single Domain Antibody Fc Fusion Protein Injection) | Phase 2 | Advanced Non-small Cell Lung Cancer | - | - |
KN026 10 mg/kg QW | Phase 2 | Gastric/Gastroesophageal Junction Cancer | - | - |
HRS-4508 tablet | Phase 2 | Solid Tumor | - | - |
Nab-paclitaxel | Phase 2 | Triple-negative Breast Cancer | - | - |
high dose KYG0395 | Phase 2 | Primary Dysmenorrhea | - | - |
Enzalutamide OR abiraterone acetate With Prednisone Acetate Tablets | Phase 2 | Metastatic Castration Resistant Prostate Cancer | - | - |
Tofacitinib Citrate Tablets | Phase 2 | Active Ankylosing Spondylitis | - | - |
VC005 groups | Phase 2 | Atopic Dermatitis | - | - |
Palonosetron | Phase 2 | Cancer | - | - |
Basic treatment | Phase 2 | Systemic Sclerosis | - | - |
SHR-1701 | Phase 2 | Pancreatic Cancer | - | - |
SHR117887 | Phase 2 | Type 2 Diabetes | - | - |
SHR-1703 | Phase 2 | Asthma With Eosinophilic Phenotype | - | - |
HR021618 | Phase 2 | Pain After Abdominal Surgery | - | - |
HS-10375 | Phase 2 | Advanced or Metastatic NSCLC | - | - |
SHR2554; SHR-A2102 | Phase 2 | Locally Advanced or Metastatic Non-small Cell Lung Cancer | - | - |
Adebrelimab | Phase 2 | Advanced KRAS G12D Mutant Solid Tumors | - | - |
COVID-19 Vaccine (Vero Cell), Inactivated | Phase 2 | COVID-19 | - | - |
FOLFOX4 | Phase 2 | Advanced Primary Liver Cancer | - | - |
STSA-1301 subcutaneous injection | Phase 2 | Primary Immune Thrombocytopenia (ITP) | - | - |
Camrelizumab、Rivoceranib | Phase 2 | Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation | - | - |
SSD8432 dose 1/Ritonavir | Phase 2 | COVID-19 Patients | - | - |
HS-20004 | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
HS-10365 capsules | Phase 2 | Nonsmall Cell Lung Cancer | - | - |
SS109 | Phase 2 | Male | - | - |
SHR0302Base gel | Phase 2 | Vitiligo | - | - |
HRS-6209 in Combination with Fulvestrant | Phase 2 | Advanced Unresectable or Metastatic Breast Cancer | - | - |
Pegylated rhG-CSF 100μg/kg | Phase 2 | Breast Cancer | - | - |
SHR-A1904 | Phase 2 | Advanced Solid Tumors | - | - |
HRS-9190 | Phase 2 | Neuromuscular Blockade | - | - |
FH-006 | Phase 2 | Malignant Solid Tumor | - | - |
HS-20094 | Phase 2 | Type 2 Diabetes | - | - |
Abiraterone Acetate Tablets (I) | Phase 2 | Metastatic Castration-resistant Prostate Cancer (mCRPC) | - | - |
Mesenchymal Stem Cells (MSCs) | Phase 2 | Chronic Radiation Proctitis | - | - |
HRS-1167 tablets | Phase 2 | Prostate Cancer | - | - |
HRS-4642 | Phase 2 | Advanced Solid Tumors | - | - |
HRS4800 tablets | Phase 2 | Pain | - | - |
SHR7280 | Phase 2 | Endometriosis | - | - |
HRS-6768 | Phase 2 | Advanced Solid Tumors | - | - |
50 mg SP2086 | Phase 2 | Type 2 Diabetes | - | - |
SHR- A1811 | Phase 2 | Gynaecological Malignancies | - | - |
Endostar | Phase 2 | Malignant Pleural Effusion | - | - |
HRS-6209 Capsules | Phase 2 | Breast Cancer | - | - |
FH-006 ; SHR-1316 ; BP102 ; Cisplatin ; Carboplatin | Phase 2 | Lung Cancer | - | - |
Edaravone Injection | Phase 2 | Acute Ischemic Stroke | - | - |
SHR-1314 | Phase 2 | Moderate-to-severe Chronic Plaque Psoriasis | - | - |
HRS-5041 tablets | Phase 2 | Prostate Cancer | - | - |
HR020602 injection | Phase 2 | Used to Induce and Implement General Anesthesia in Combination With Sedative Anesthetics (Such as Propofol) | - | - |
ACC017+FTC/TAF | Phase 2 | Infection, Human Immunodeficiency Virus | - | - |
Fluzoparib+Apatinib | Phase 2 | Relapsed Ovarian Cancer | - | - |
Venetoclax | Phase 2 | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | - | - |
Insulin Degludec | Phase 2 | Type 2 Diabetes | - | - |
HRS-6213 | Phase 2 | Patients With Solid Tumors | - | - |
ASKB589 Injection | Phase 2 | Malignant Solid Tumor | - | - |
SHR 1210+apatinib | Phase 2 | Hepatocellular Carcinoma | - | - |
Vicagrel 5mg | Phase 2 | Coronary Artery Disease | - | - |
HR19042 Capsules | Phase 2 | Autoimmune Hepatitis | - | - |
Bendamustine hydrochloride injection | Phase 2 | Chronic Lymphocytic Leukemia | - | - |
Human TH-SC01 cell injection | Phase 2 | Perianal Fistula | - | - |
SHR-A1811 combined with Pyrotinib. | Phase 2 | HER2-expressing Advanced Solid Tumors | - | - |
SHR-3167 | Phase 2 | Type 2 Diabetes | - | - |
Fluzoparib | Phase 2 | Small Cell Lung Cancer | - | - |